| 0 (0%) | 04-26 18:14 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 12.36 | 1-year : | 14.44 |
| Resists | First : | 10.59 | Second : | 12.36 |
| Pivot price | 10.54  |
|||
| Supports | First : | 10.53 | Second : | 10.5 |
| MAs | MA(5) : | 10.58 |
MA(20) : | 10.54 |
| MA(100) : | 10.45 |
MA(250) : | 10.32 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 95.2  |
D(3) : | 96 |
| RSI | RSI(14): 71.7 | |||
| 52-week | High : | 11.55 | Low : | 10.1 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ ATA ] has closed below upper band by 16.2%. Bollinger Bands are 12.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 10.59 - 10.64 | 10.64 - 10.7 |
| Low: | 10.46 - 10.51 | 10.51 - 10.57 |
| Close: | 10.5 - 10.58 | 10.58 - 10.67 |
Fri, 26 Apr 2024
Atea First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St
Wed, 24 Apr 2024
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Stock Position Increased by BML Capital Management LLC - MarketBeat
Tue, 23 Apr 2024
Atea ASA: Presentation of 2nd quarter results 2014 - Yahoo Lifestyle UK
Tue, 23 Apr 2024
ATEA in the US signs MoU with Southern India Chamber of Commerce and Industry to widen business - indica News
Wed, 27 Mar 2024
Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral ... - GlobeNewswire
Thu, 14 Mar 2024
Atea's once-daily antiviral treatment clears HCV in 4 weeks in trial - Liver Disease News
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 7 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 50.7 (%) |
| Held by Institutions | 50.1 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 1 (K) |
| EPS | 0.07 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.57 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 151.21 |
| PEG Ratio | 0 |
| Price to Book value | -18.91 |
| Price to Sales | 0 |
| Price to Cash Flow | -71.98 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|